361 related articles for article (PubMed ID: 29617665)
1. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers.
Peng X; Chen Z; Farshidfar F; Xu X; Lorenzi PL; Wang Y; Cheng F; Tan L; Mojumdar K; Du D; Ge Z; Li J; Thomas GV; Birsoy K; Liu L; Zhang H; Zhao Z; Marchand C; Weinstein JN; ; Bathe OF; Liang H
Cell Rep; 2018 Apr; 23(1):255-269.e4. PubMed ID: 29617665
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer characterization of metabolism-related biomarkers identifies potential therapeutic targets.
Bi G; Bian Y; Liang J; Yin J; Li R; Zhao M; Huang Y; Lu T; Zhan C; Fan H; Wang Q
J Transl Med; 2021 May; 19(1):219. PubMed ID: 34030708
[TBL] [Abstract][Full Text] [Related]
3. Metabolic gene alterations impact the clinical aggressiveness and drug responses of 32 human cancers.
Sinkala M; Mulder N; Patrick Martin D
Commun Biol; 2019; 2():414. PubMed ID: 31754644
[TBL] [Abstract][Full Text] [Related]
4. Targeting TYRO3 inhibits epithelial-mesenchymal transition and increases drug sensitivity in colon cancer.
Chien CW; Hou PC; Wu HC; Chang YL; Lin SC; Lin SC; Lin BW; Lee JC; Chang YJ; Sun HS; Tsai SJ
Oncogene; 2016 Nov; 35(45):5872-5881. PubMed ID: 27132510
[TBL] [Abstract][Full Text] [Related]
5. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
[TBL] [Abstract][Full Text] [Related]
6. Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas.
Rosario SR; Long MD; Affronti HC; Rowsam AM; Eng KH; Smiraglia DJ
Nat Commun; 2018 Dec; 9(1):5330. PubMed ID: 30552315
[TBL] [Abstract][Full Text] [Related]
7. Integration of transcriptomic data and metabolic networks in cancer samples reveals highly significant prognostic power.
Graudenzi A; Maspero D; Di Filippo M; Gnugnoli M; Isella C; Mauri G; Medico E; Antoniotti M; Damiani C
J Biomed Inform; 2018 Nov; 87():37-49. PubMed ID: 30244122
[TBL] [Abstract][Full Text] [Related]
8. Lactate-induced MRP1 expression contributes to metabolism-based etoposide resistance in non-small cell lung cancer cells.
Dong Q; Zhou C; Ren H; Zhang Z; Cheng F; Xiong Z; Chen C; Yang J; Gao J; Zhang Y; Xu L; Fang J; Cao Y; Wei H; Wu Z
Cell Commun Signal; 2020 Oct; 18(1):167. PubMed ID: 33097055
[TBL] [Abstract][Full Text] [Related]
9. Integration of transcriptome and cistrome analysis identifies RUNX1-target genes involved in pancreatic cancer proliferation.
Liu S; Xie F; Gan L; Peng T; Xu X; Guo S; Fu W; Wang Y; Ouyang Y; Yang J; Wang X; Zheng Y; Zhang J; Wang H
Genomics; 2020 Nov; 112(6):5343-5355. PubMed ID: 33189780
[TBL] [Abstract][Full Text] [Related]
10. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types.
Ge Z; Leighton JS; Wang Y; Peng X; Chen Z; Chen H; Sun Y; Yao F; Li J; Zhang H; Liu J; Shriver CD; Hu H; ; Piwnica-Worms H; Ma L; Liang H
Cell Rep; 2018 Apr; 23(1):213-226.e3. PubMed ID: 29617661
[TBL] [Abstract][Full Text] [Related]
11. Runx1 Orchestrates Sphingolipid Metabolism and Glucocorticoid Resistance in Lymphomagenesis.
Kilbey A; Terry A; Wotton S; Borland G; Zhang Q; Mackay N; McDonald A; Bell M; Wakelam MJ; Cameron ER; Neil JC
J Cell Biochem; 2017 Jun; 118(6):1432-1441. PubMed ID: 27869314
[TBL] [Abstract][Full Text] [Related]
12. Identification of Personalized Chemoresistance Genes in Subtypes of Basal-Like Breast Cancer Based on Functional Differences Using Pathway Analysis.
Wu T; Wang X; Li J; Song X; Wang Y; Wang Y; Zhang L; Li Z; Tian J
PLoS One; 2015; 10(6):e0131183. PubMed ID: 26126114
[TBL] [Abstract][Full Text] [Related]
13. SNAIL1 employs β-Catenin-LEF1 complexes to control colorectal cancer cell invasion and proliferation.
Freihen V; Rönsch K; Mastroianni J; Frey P; Rose K; Boerries M; Zeiser R; Busch H; Hecht A
Int J Cancer; 2020 Apr; 146(8):2229-2242. PubMed ID: 31463973
[TBL] [Abstract][Full Text] [Related]
14. Inflammation-driven colon neoplasmatogenesis in uPA-deficient mice is associated with an increased expression of Runx transcriptional regulators.
Afaloniati H; Karagiannis GS; Hardas A; Poutahidis T; Angelopoulou K
Exp Cell Res; 2017 Dec; 361(2):257-264. PubMed ID: 29107070
[TBL] [Abstract][Full Text] [Related]
15. Gene Expression Integration into Pathway Modules Reveals a Pan-Cancer Metabolic Landscape.
Cubuk C; Hidalgo MR; Amadoz A; Pujana MA; Mateo F; Herranz C; Carbonell-Caballero J; Dopazo J
Cancer Res; 2018 Nov; 78(21):6059-6072. PubMed ID: 30135189
[TBL] [Abstract][Full Text] [Related]
16. Snail augments fatty acid oxidation by suppression of mitochondrial ACC2 during cancer progression.
Yang JH; Kim NH; Yun JS; Cho ES; Cha YH; Cho SB; Lee SH; Cha SY; Kim SY; Choi J; Nguyen TM; Park S; Kim HS; Yook JI
Life Sci Alliance; 2020 Jul; 3(7):. PubMed ID: 32487689
[TBL] [Abstract][Full Text] [Related]
17. Pan-Cancer Analysis of Glycolytic and Ketone Bodies Metabolic Genes: Implications for Response to Ketogenic Dietary Therapy.
Qian L; Li Y; Cao Y; Meng G; Peng J; Li H; Wang Y; Xu T; Zhang L; Sun B; Li B; Yu D
Front Oncol; 2021; 11():689068. PubMed ID: 34692477
[TBL] [Abstract][Full Text] [Related]
18. Identification and Characterization of Metabolic Subtypes of Endometrial Cancer Using a Systems-Level Approach.
Srivastava A; Vinod PK
Metabolites; 2023 Mar; 13(3):. PubMed ID: 36984849
[TBL] [Abstract][Full Text] [Related]
19. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
Schaeffeler E; Büttner F; Reustle A; Klumpp V; Winter S; Rausch S; Fisel P; Hennenlotter J; Kruck S; Stenzl A; Wahrheit J; Sonntag D; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M
Eur Urol Focus; 2019 Jul; 5(4):608-618. PubMed ID: 29452772
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-regulated transcriptome analysis identifies four major subtypes with prognostic and therapeutic implications in prostate cancer.
Lin BB; Lei HQ; Xiong HY; Fu X; Shi F; Yang XW; Yang YF; Liao GL; Feng YP; Jiang DG; Pang J
Comput Struct Biotechnol J; 2021; 19():4941-4953. PubMed ID: 34527198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]